239 related articles for article (PubMed ID: 9150409)
1. Site-directed mutagenesis of active site contact residues in a hydrolytic abzyme: evidence for an essential histidine involved in transition state stabilization.
Miyashita H; Hara T; Tanimura R; Fukuyama S; Cagnon C; Kohara A; Fujii I
J Mol Biol; 1997 Apr; 267(5):1247-57. PubMed ID: 9150409
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of the transition-state stabilization in antibody-catalyzed hydrolysis.
Sakakura M; Takahashi H; Shimba N; Fujii I; Shimada I
J Mol Biol; 2007 Mar; 367(1):133-47. PubMed ID: 17239396
[TBL] [Abstract][Full Text] [Related]
3. Thermodynamic and structural basis for transition-state stabilization in antibody-catalyzed hydrolysis.
Oda M; Ito N; Tsumuraya T; Suzuki K; Sakakura M; Fujii I
J Mol Biol; 2007 May; 369(1):198-209. PubMed ID: 17428500
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of improvement of hydrolytic antibody 6D9 by site-directed mutagenesis.
Takahashi-Ando N; Shimazaki K; Kakinuma H; Fujii I; Nishi Y
J Biochem; 2006 Oct; 140(4):509-15. PubMed ID: 16921165
[TBL] [Abstract][Full Text] [Related]
5. Identification of functionally important residues in the pyridoxal-5'-phosphate-dependent catalytic antibody 15A9.
Mouratou B; Stetefeld J
Biochemistry; 2004 Jun; 43(21):6612-9. PubMed ID: 15157094
[TBL] [Abstract][Full Text] [Related]
6. Probing the importance of second sphere residues in an esterolytic antibody by phage display.
Arkin MR; Wells JA
J Mol Biol; 1998 Dec; 284(4):1083-94. PubMed ID: 9837728
[TBL] [Abstract][Full Text] [Related]
7. A structural basis for transition-state stabilization in antibody-catalyzed hydrolysis: crystal structures of an abzyme at 1. 8 A resolution.
Kristensen O; Vassylyev DG; Tanaka F; Morikawa K; Fujii I
J Mol Biol; 1998 Aug; 281(3):501-11. PubMed ID: 9698565
[TBL] [Abstract][Full Text] [Related]
8. Catalytic antibody model and mutagenesis implicate arginine in transition-state stabilization.
Roberts VA; Stewart J; Benkovic SJ; Getzoff ED
J Mol Biol; 1994 Jan; 235(3):1098-116. PubMed ID: 8289310
[TBL] [Abstract][Full Text] [Related]
9. In vitro abzyme evolution to optimize antibody recognition for catalysis.
Takahashi N; Kakinuma H; Liu L; Nishi Y; Fujii I
Nat Biotechnol; 2001 Jun; 19(6):563-7. PubMed ID: 11385462
[TBL] [Abstract][Full Text] [Related]
10. Directed evolution governed by controlling the molecular recognition between an abzyme and its haptenic transition-state analog.
Takahashi-Ando N; Kakinuma H; Fujii I; Nishi Y
J Immunol Methods; 2004 Nov; 294(1-2):1-14. PubMed ID: 15604011
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for amide hydrolysis catalyzed by the 43C9 antibody.
Thayer MM; Olender EH; Arvai AS; Koike CK; Canestrelli IL; Stewart JD; Benkovic SJ; Getzoff ED; Roberts VA
J Mol Biol; 1999 Aug; 291(2):329-45. PubMed ID: 10438624
[TBL] [Abstract][Full Text] [Related]
12. Crystallographic and biochemical analysis of cocaine-degrading antibody 15A10.
Larsen NA; de Prada P; Deng SX; Mittal A; Braskett M; Zhu X; Wilson IA; Landry DW
Biochemistry; 2004 Jun; 43(25):8067-76. PubMed ID: 15209502
[TBL] [Abstract][Full Text] [Related]
13. Analysis of hapten binding and catalytic determinants in a family of catalytic antibodies.
Ulrich HD; Schultz PG
J Mol Biol; 1998 Jan; 275(1):95-111. PubMed ID: 9451442
[TBL] [Abstract][Full Text] [Related]
14. Site-directed mutagenesis of active site residues of phosphite dehydrogenase.
Woodyer R; Wheatley JL; Relyea HA; Rimkus S; van der Donk WA
Biochemistry; 2005 Mar; 44(12):4765-74. PubMed ID: 15779903
[TBL] [Abstract][Full Text] [Related]
15. On the catalytic role of the conserved active site residue His466 of choline oxidase.
Ghanem M; Gadda G
Biochemistry; 2005 Jan; 44(3):893-904. PubMed ID: 15654745
[TBL] [Abstract][Full Text] [Related]
16. Improving GPX activity of selenium-containing human single-chain Fv antibody by site-directed mutation based on the structural analysis.
Xu J; Song J; Yan F; Chu H; Luo J; Zhao Y; Cheng X; Luo G; Zheng Q; Wei J
J Mol Recognit; 2009; 22(4):293-300. PubMed ID: 19277948
[TBL] [Abstract][Full Text] [Related]
17. Positional ordering of reacting groups contributes significantly to the efficiency of proton transfer at an antibody active site.
Seebeck FP; Hilvert D
J Am Chem Soc; 2005 Feb; 127(4):1307-12. PubMed ID: 15669871
[TBL] [Abstract][Full Text] [Related]
18. The roles of active-site residues in the catalytic mechanism of trans-3-chloroacrylic acid dehalogenase: a kinetic, NMR, and mutational analysis.
Azurmendi HF; Wang SC; Massiah MA; Poelarends GJ; Whitman CP; Mildvan AS
Biochemistry; 2004 Apr; 43(14):4082-91. PubMed ID: 15065850
[TBL] [Abstract][Full Text] [Related]
19. Enzymatic characterization of glycosidase antibodies raised against a chair transition state analog and the retained catalytic activity from the expressed single chain antibody fragments.
Choi SO; Youn HJ; Yu J
Mol Cells; 2002 Jun; 13(3):463-9. PubMed ID: 12132587
[TBL] [Abstract][Full Text] [Related]
20. Site-directed mutagenesis of proteolytic antibody light chain.
Gao QS; Sun M; Rees AR; Paul S
J Mol Biol; 1995 Nov; 253(5):658-64. PubMed ID: 7473741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
